Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,446
Views
4
CrossRef citations to date
0
Altmetric
Research paper

LINC00998 functions as a novel tumor suppressor in acute myeloid leukemia via regulating the ZFP36 ring finger protein/mammalian target of rapamycin complex 2 axis

Ximin Fanga Department of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, China;b Department of Hematology-Oncology, Shenzhen Children’s Hospital, Shenzhen, ChinaView further author information
,
Xiazhen Panc Department of Intensive Care Unit, The University of Hong Kong-Shenzhen Hospital, Shenzhen, ChinaView further author information
,
Huirong Maib Department of Hematology-Oncology, Shenzhen Children’s Hospital, Shenzhen, ChinaView further author information
,
Xiuli Yuanb Department of Hematology-Oncology, Shenzhen Children’s Hospital, Shenzhen, ChinaView further author information
,
Sixi Liub Department of Hematology-Oncology, Shenzhen Children’s Hospital, Shenzhen, ChinaView further author information
&
Feiqiu Wena Department of Pediatrics, The First Affiliated Hospital of Jinan University, Guangzhou, China;b Department of Hematology-Oncology, Shenzhen Children’s Hospital, Shenzhen, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8303-7981View further author information
ORCID Icon
Pages 10363-10372 | Received 26 Jun 2021, Accepted 16 Oct 2021, Published online: 02 Dec 2021

References

  • Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
  • Ben KM, Ingegnere T, Quesnel B, et al. Acute myeloid leukemia: is it T time? Cancers (Basel). 2021;13(10):2385.
  • Sami SA, Darwish N, Barile A, et al. Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy. Curr Treat Options Oncol. 2020;21(1):3.
  • Erdmann VA, Barciszewska MZ, Hochberg A, et al. Regulatory RNAs. Cell Mol Life Sci. 2001;58(7):960–977.
  • Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol. 2010;220(2):126–139.
  • Ghafouri-Fard S, Esmaeili M, Taheri M. Expression of non-coding RNAs in hematological malignancies. Eur J Pharmacol. 2020;875:172976.
  • Ren X. Genome-wide analysis reveals the emerging roles of long non-coding RNAs in cancer. Oncol Lett. 2020;19(1):588–594.
  • Tripathi R, Chakraborty P, Varadwaj PK. Unraveling long non-coding RNAs through analysis of high-throughput RNA-sequencing data. Noncoding RNA Res. 2017;2(2):111–118.
  • Deng SJ, Chen HY, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37(44):5811–5828.
  • Tang C, Feng W, Bao Y, et al. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP). Bioengineered. 2021;12(1):2119–2131.
  • Zhang JX, Chen ZH, Chen DL, et al. LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis. Oncogene. 2018;37(20):2660–2675.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Zhu X, Jiang S, Wu Z, et al. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Bioengineered. 2021;12(1):578–588.
  • Wang G, Wu H, Liang P, et al. Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-beta1/Smad pathway. Bioengineered. 2021;12(1):1415–1425.
  • Chi Y, Wang D, Wang J, et al. Long Non-Coding RNA in the Pathogenesis of Cancers. Cells-Basel. 2019;8(9):1015.
  • Chen Y, Li Z, Chen X, et al. Long non-coding RNAs: from disease code to drug role. Acta Pharm Sin B. 2021;11(2):340–354.
  • Silva-Fisher JM, Dang HX, White NM, et al. Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression. Nat Commun. 2020;11(1):2156.
  • Xie JJ, Jiang YY, Jiang Y, et al. Super-enhancer-driven long non-coding RNA LINC01503, regulated by TP63, is over-expressed and oncogenic in squamous cell carcinoma. Gastroenterology. 2018;154(8):2137–2151.
  • Fan S, Tian T, Lv X, et al. lncRNA CISAL inhibits BRCA1 transcription by forming a tertiary structure at its promoter. iScience. 2020;23(2):100835.
  • Ferre F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116.
  • Qu X, Alsager S, Zhuo Y, et al. HOX transcript antisense RNA (HOTAIR) in cancer. Cancer Lett. 2019;454:90–97.
  • Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689–693.
  • Xu L, Huan L, Guo T, et al. LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1alpha. Oncogene. 2020;39(46):7005–7018.
  • Holmes B, Artinian N, Anderson L, et al. Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress. Cell Signal. 2012;24(1):309–315.
  • Kim LC, Cook RS, Chen J. mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene. 2017;36(16):2191–2201.
  • Herschbein L, Liesveld JL. Dueling for dual inhibition: means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML. Blood Rev. 2018;32(3):235–248.
  • Cai H, Yu Y, Ni X, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020;11(12):1032.
  • Sun LY, Li XJ, Sun YM, et al. LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1. Mol Cancer. 2018;17(1):127.
  • Luo H, Zhu G, Xu J, et al. HOTTIP lncRNA promotes hematopoietic stem cell self-renewal leading to AML-like disease in mice. Cancer Cell. 2019;36(6):645–659.
  • Zhou H, Jia X, Yang F, et al. Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2ʹ-5ʹ-oligoadenylate synthetase 2 axis in acute myeloid leukemia. Bioengineered. 2021;12(1):6403–6417.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.